Oxford Immunotech (AgeTech UK) Covid-19
Treatment for chronic diseases for patients with compromised immuno-system, e.g HIV/AIDS, might be Covid-relevant.
Connections from
.png)
Technology:
AgeTech Companies
Headquarters:
United Kingdom
Funding Status:
N/A
Investment Stage:
N/A
Founded Date:
N/A
Number Of Exists:
N/A
Employee Number:
N/A
Industry:
UK AgeTech 2020
Investor Type:
N/A